🇺🇸 Minodronic acid hydrate in United States

23 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Decreased Appetite — 4 reports (17.39%)
  2. Fall — 3 reports (13.04%)
  3. Acute Myeloid Leukaemia — 2 reports (8.7%)
  4. Amaurosis Fugax — 2 reports (8.7%)
  5. Gastritis — 2 reports (8.7%)
  6. Loss Of Consciousness — 2 reports (8.7%)
  7. Melaena — 2 reports (8.7%)
  8. Nausea — 2 reports (8.7%)
  9. Platelet Count Decreased — 2 reports (8.7%)
  10. Pneumonia — 2 reports (8.7%)

Source database →

Other Bone metabolism / Osteoporosis approved in United States

Frequently asked questions

Is Minodronic acid hydrate approved in United States?

Minodronic acid hydrate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Minodronic acid hydrate in United States?

Ono Pharmaceutical Co. Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.